Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Medicus Pharma MDCX Price Action Q4 2025 Below Expectations Franklin FBRT Market Dynamics Franklin BSP Realty Trust posts 577 EPS miss Bassett BSET Stock Valuation Breakdown Marginal Loss 20260418 IMCR Immunocore shares rise 156 percent on 289 percent Q4 2025 revenue growth despite wider than expected loss The debt management strategy at Zhibao ZBAO ZBAO Quarterly Earnings Zhibao Reports No Revenue Figures Independent IBCP Stock Risk Factors Touches Low 20260420 Gorilla GRRR Stock Underpriced 036 20260420 Sezzle SEZL Q1 2026 Earnings 147 EPS Surges Past 126 Estimates Eaton ETN Slides 212 as Selling Pressure Mounts 20260515 Vivid Seats SEAT Reports Mixed Q1 2026 Revenue Beats but EPS Misses Danaos DAC Stock Up 146 Key Resistance at 13868 20260518 Snail SNAL Stock Analysis 2155 Loss Key Levels 20260518 AI Infrastructure MegaDeal Tech Titans Pledge Up to 500 Billion for US Data Centers Asian Currencies Signal Growing Oil Shock Concerns Analysts Warn Vanguard Corporate Releases Economic Outlook for Canada A ForwardLooking Assessment AustralianSuper Views Potential Glencore Listing on ASX as Positive Move Bitcoin ETFs See 226 Billion in Outflows Over Two Weeks AnheuserBusch InBev Shares Dip on Sales Miss Market Reacts to Revenue Shortfall AI Could Accelerate Discovery of Affordable Treatments for Brain Conditions Like MND GABC Q1 2026 Earnings EPS Misses Estimates Amid Slight Stock Decline GROY Q1 2026 Earnings Slight EPS Miss Amidst Quiet Quarter BioVie Inc BIVI Q1 2026 Earnings Narrowing Losses and Clinical Progress Buoy Investor Sentiment APWC Q3 1997 Earnings EPS Falls 287 Short of Estimates Stock Rises Despite Miss cbdMD Inc YCBD Q1 2026 Earnings WiderThanExpected Loss Highlights Ongoing Challenges VLTO Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Performance Sportradar Group SRAD Edges Higher Holding Above Key Support Amid Modest Volume Fortune Brands Innovations FBIN Rallies 195 as Stock Tests Key Resistance Zone Pyxis Oncology PYXS Shows Resilience with 289 Gain Approaches Key Resistance InMode INMD Pushes Higher Testing Resistance After a 16 Gain WR Berkley WRB Holds Steady Near Support Amid Modest Pullback